PT77034A - Process for the preparation of a phenylalkylaminoethylsalicylamide - Google Patents
Process for the preparation of a phenylalkylaminoethylsalicylamideInfo
- Publication number
- PT77034A PT77034A PT7703483A PT7703483A PT77034A PT 77034 A PT77034 A PT 77034A PT 7703483 A PT7703483 A PT 7703483A PT 7703483 A PT7703483 A PT 7703483A PT 77034 A PT77034 A PT 77034A
- Authority
- PT
- Portugal
- Prior art keywords
- aryl
- prepn
- glycyl
- phenylpropyl
- esp
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Prepn. of (-)-5-((R)-1-hydroxy 2-((R)-1-methyl-3-phenylpropyl) aminoethyl)salicylamide (I) or its acid-addn. salts includes the redn. of the glycyl carbonyl function of a 2-(opt. protected OH)-5-(N-protected-N-((R) 1-methyl-3-phenylpropyl) glycyl)benzamide (II). The N-protecting gp. is a (R)-ArCHY-qp. (Ar is aryl esp. aryl having a single benzene ring; and Y is 1-6C alkyl) esp. (R)-alpha-methylbenzyl go. Intermediates of formula (IIa) are new. (Ar is aryl: Y is 1-6C alkyl; Z is H or 3-(H2NOC)-4-(P'O)C6H3X-CH2; p' is a protecting gp. removable by hydrogenolysis; and X is CO or (R1S)CH(OH)). (I) is one of the 4 optically active stereoisomers found in the antihypertensive agent labetalol described in US4012444, and (I) and its prepn. are described in EP--9702. By using the stereospecific intermediates (II), which can be obtd. by resolution through salt formation, without the need for chromatographic sepns. etc.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT7703483A PT77034B (en) | 1983-07-15 | 1983-07-15 | Process for the preparation of a phenylalkylaminoethylsalicylamide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT7703483A PT77034B (en) | 1983-07-15 | 1983-07-15 | Process for the preparation of a phenylalkylaminoethylsalicylamide |
Publications (2)
Publication Number | Publication Date |
---|---|
PT77034A true PT77034A (en) | 1983-08-01 |
PT77034B PT77034B (en) | 1986-01-28 |
Family
ID=20083337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT7703483A PT77034B (en) | 1983-07-15 | 1983-07-15 | Process for the preparation of a phenylalkylaminoethylsalicylamide |
Country Status (1)
Country | Link |
---|---|
PT (1) | PT77034B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113698316A (en) * | 2021-09-03 | 2021-11-26 | 安徽美致诚药业有限公司 | Preparation method of labetalol hydrochloride |
-
1983
- 1983-07-15 PT PT7703483A patent/PT77034B/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113698316A (en) * | 2021-09-03 | 2021-11-26 | 安徽美致诚药业有限公司 | Preparation method of labetalol hydrochloride |
CN113698316B (en) * | 2021-09-03 | 2022-04-19 | 安徽美致诚药业有限公司 | Preparation method of labetalol hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
PT77034B (en) | 1986-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO843836L (en) | THERAPEUTIC ACTIVE SULPHAMATE DERIVATIVES | |
PH17740A (en) | Substituted acyl derivatives of 1-2,3,4 tetrahydro-isoquinoline-3-carboxylic acids,their pharmaceutical compositions and use | |
DE69214466D1 (en) | POLYMER COATING | |
EP0353955A3 (en) | Novel compounds | |
ES8609204A1 (en) | Phenylisopropylamine derivative and its preparation. | |
DE3068029D1 (en) | Intermediates for the preparation of thienamycin and process for preparing intermediates | |
ES2045067T3 (en) | PROCEDURE FOR PREPARING NEW TIAZOL COMPOUNDS. | |
DK0643690T3 (en) | Desferrioxamine B salts as well as their use as orally active iron chelating agents | |
PT77034A (en) | Process for the preparation of a phenylalkylaminoethylsalicylamide | |
HU9301388D0 (en) | Method for producing hydroxy-ethylene-isoster type compounds of hiv-protease inhibiting effect containing dithiolamine-glycine | |
MY103393A (en) | 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof | |
WO1990003172A3 (en) | Bile acids for treatment of viral infections | |
MY103910A (en) | 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof | |
GR3017557T3 (en) | Novel amino acid derivatives. | |
AU683148B2 (en) | Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases | |
ES2017633B3 (en) | AMIDO DERIVATIVES. | |
MY130190A (en) | Method for the preparation of 4-halo-2'- nitrobutyrophenone compounds | |
ES8603434A1 (en) | 1,2,4-Triazolylpropanols, and their production and use. | |
JPS5533499A (en) | N2-arylsulfonyl-l-arginineamide and its pharmaceutically acceptable salt | |
KR840001580A (en) | Method for preparing 6 '-(2-amino-2- [4-acylbathoxyphenyl] acetamidophenicilanoyloxymethyl penicylanate 1,1-dioxide compound | |
ES8504736A1 (en) | Optically active imidazolylpropanol compounds, and their production and use. | |
FI955282A0 (en) | Process for the preparation of NG-monoalkyl-L-arginine and the corresponding compounds | |
MX9603868A (en) | Pharmaceutical composition of indene derivatives for regulating apoptosis. | |
JPS56108760A (en) | Propionic acid derivative and its preparation | |
HUT63836A (en) | Process for producing acridine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19920129 |